Eric Bachelder, PhD, Scientific Advisory Board Invented new class of polymers that have implications for vaccines, antibiotics, siRNA delivery, and for other therapeutic applications. Key advisor for advanced immune therapies, nano- and micro-particulate carriers, and the formulation of novel polymers.

Eric Bachelder, PhD, Scientific Advisory Board

Invented new class of polymers that have implications for vaccines, antibiotics, siRNA delivery, and for other therapeutic applications.

Key advisor for advanced immune therapies, nano- and micro-particulate carriers, and the formulation of novel polymers.

David Wyatt, MS, Scientific Advisory Board Executive-level business and technical experience in the development of controlled release pharmaceuticals.  Expertise in the use of GMP excipients for targeted release of active compounds. Key advisor for early-stage product development and commercialization.

David Wyatt, MS, Scientific Advisory Board

Executive-level business and technical experience in the development of controlled release pharmaceuticals.  Expertise in the use of GMP excipients for targeted release of active compounds.

Key advisor for early-stage product development and commercialization.

April Lewis Mitchell, MBA, Pharma Advisor Recognized as industry leader in Pharma sector, having worked at small start up and blue chip pharmaceutical companies. Has led fully-integrated launch marketing campaigns across a variety of therapeutic products totaling over $5B in sales.  Key advisor for commercialization efforts specific to scientific promotion via KOL utilization and sales force strategy and execution of Peptineo solutions for drug delivery.

April Lewis Mitchell, MBA, Pharma Advisor

Recognized as industry leader in Pharma sector, having worked at small start up and blue chip pharmaceutical companies. Has led fully-integrated launch marketing campaigns across a variety of therapeutic products totaling over $5B in sales. 

Key advisor for commercialization efforts specific to scientific promotion via KOL utilization and sales force strategy and execution of Peptineo solutions for drug delivery.

George Tegos, PhD, Scientific Advisory Board Domain expertise in antibiotics, multi-drug resistance pumps, photodynamic therapeutic strategies, and in other therapeutic applications.  Key advisor for first drug delivery initiative based on technologies being commercialized by Peptineo.

George Tegos, PhD, Scientific Advisory Board

Domain expertise in antibiotics, multi-drug resistance pumps, photodynamic therapeutic strategies, and in other therapeutic applications. 

Key advisor for first drug delivery initiative based on technologies being commercialized by Peptineo.

Roshan Yoganathan, PhD, Scientific Advisory Board Domain expertise in biomaterials and drug delivery.  Responsible for small molecule formulations targeting cancer and ocular diseases. Key advisor for scale-up of bio-processes and cell therapies for clinical trials. Veteran to start-up initiatives.

Roshan Yoganathan, PhD, Scientific Advisory Board

Domain expertise in biomaterials and drug delivery.  Responsible for small molecule formulations targeting cancer and ocular diseases.

Key advisor for scale-up of bio-processes and cell therapies for clinical trials. Veteran to start-up initiatives.

Kamal Garcha, PhD, Scientific Advisory Board Domain expertise in human disease modeling using induced pluripotent stem cells (iPSCs).  Key advisor for drug discovery, drug delivery, and commercialization of platform technologies.

Kamal Garcha, PhD, Scientific Advisory Board

Domain expertise in human disease modeling using induced pluripotent stem cells (iPSCs). 

Key advisor for drug discovery, drug delivery, and commercialization of platform technologies.

David McClain, MA, Pharma and Digital Sales Advisor Recognized as expert in enhancing brand awareness via multi-platform advertising solutions. Key advisor for Pharma life-cycle planning, sales process, and digital strategies for advertising and promotion.

David McClain, MA, Pharma and Digital Sales Advisor

Recognized as expert in enhancing brand awareness via multi-platform advertising solutions.

Key advisor for Pharma life-cycle planning, sales process, and digital strategies for advertising and promotion.

Kristy Ainslie, PhD, Scientific Advisory Board Recognized as emerging innovator in drug delivery platforms and selected by DARPA for 7 day vaccine challenge targeting an unknown pathogen. Key advisor for therapeutic delivery, dextran-based formulations, and novel polymer development.

Kristy Ainslie, PhD, Scientific Advisory Board

Recognized as emerging innovator in drug delivery platforms and selected by DARPA for 7 day vaccine challenge targeting an unknown pathogen.

Key advisor for therapeutic delivery, dextran-based formulations, and novel polymer development.

Robert Applegate, PhD, Scientific Advisory Board Recognized as emerging innovator in micro-fluidics, biomedical devices and optical technologies. Veteran to start-up initiatives. Key advisor for microfluidic manipulation, flow cytometers, next-generation DNA sequencing and nano droplet cosmeseuticals.

Robert Applegate, PhD, Scientific Advisory Board

Recognized as emerging innovator in micro-fluidics, biomedical devices and optical technologies. Veteran to start-up initiatives.

Key advisor for microfluidic manipulation, flow cytometers, next-generation DNA sequencing and nano droplet cosmeseuticals.

Danny Knee, BBA, DOD Strategic Advisor Industry veteran for Defense & Space business development activities. Key advisor for Department of Defense initiatives including vaccine development, medical countermeasures, biodefense, and bio-inspired manufacturing.

Danny Knee, BBA, DOD Strategic Advisor

Industry veteran for Defense & Space business development activities. Key advisor for Department of Defense initiatives including vaccine development, medical countermeasures, biodefense, and bio-inspired manufacturing.